Case study
I was diagnosed with relapsing-remitting MS two months ago; I also have Crohn's. I was told I would usually be offered ocrelizumab (Ocrevus), but due to my Crohn's, I have only been provided a mid-efficacy DMT. I have unhappily agreed to dimethyl fumarate (Tecfidera). I asked for natalizumab (Tysrabi) but was told I did not meet the NICE criteria. I have an aunt who has been a wheelchair user for the last 20 years due to a bad relapse. I want to argue my case for a higher-efficacy DMT. My GP and gastro have agreed with me and are willing to write supportive letters. Can you give me any advice on what else I can do? Everything I have read says a high-efficacy DMT from diagnosis is the best treatment.
NOTE: General substack newsletters and microsite are free; only Q&A sessions are restricted to paying subscribers. I can't run and maintain the MS-Selfie microsite, hence the need to pay people to help me do the work. If people want to ask medical questions unrelated to the Newsletters or Podcasts, they either need to become paying subscribers or email (ms-selfie@giovannoni.net) to request a complimentary subscription.
Prof G’s answer
Yes, but ……
Should ublituximab be prioritised over ocrelizumab and ofatumumab as a treatment for MS? …..
Listen to this episode with a 7-day free trial
Subscribe to MS-Selfie to listen to this post and get 7 days of free access to the full post archives.
